Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

Clinical trial NCT05925803 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05925803
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Sclerosis Scleroderma

Start date: 2023-11-08
Primary completion: 2027-01-06
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.